A 54-year-old woman is evaluated during a follow-up visit for chronic osteomyelitis. She has type 2 diabetes mellitus complicated by nephropathy and peripheral neuropathy and was recently diagnosed with osteomyelitis of the left foot associated with a chronic neuropathic ulcer. Bone biopsy and culture demonstrated methicillin-sensitive Staphylococcus aureus, and 1 week ago she was started on oral high-dose trimethoprim-sulfamethoxazole and rifampin based on sensitivity data for a planned 6-week course of therapy. Medical history is also significant for hypertension. Medications are trimethoprim-sulfamethoxazole, rifampin, glipizide, and atorvastatin.
On physical examination today, temperature is 37.2 °C (99.0 °F), blood pressure is 126/66 mm Hg, and pulse rate is 78/min. Chest, heart, and abdominal examinations are unremarkable. There is loss of sensation to light touch on the feet bilaterally to the ankles. The ulcer overlying the first metatarsal head on the plantar aspect of the left foot is clean and dry.
Blood urea nitrogen | 28 mg/dL (10 mmol/L) (pretreatment baseline: 26 mg/dL [9.3 mmol/L]) |
Creatinine | 1.8 mg/dL (159.1 µmol/L) (pretreatment baseline: 1.4 mg/dL [123.8 µmol/L]) |
Potassium | 4.7 mEq/L (4.7 mmol/L) |
Which of the following is the most appropriate management?